Tamim Shaikh
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abnormalities, Multiple | 14 | 2015 | 176 | 2.470 |
Why?
| Chromosome Deletion | 16 | 2021 | 95 | 2.460 |
Why?
| DNA Copy Number Variations | 9 | 2023 | 156 | 1.820 |
Why?
| Chromosomes, Human, Pair 22 | 15 | 2019 | 39 | 1.540 |
Why?
| Craniofacial Abnormalities | 7 | 2021 | 59 | 1.230 |
Why?
| Oligonucleotide Array Sequence Analysis | 18 | 2011 | 746 | 1.190 |
Why?
| Heart Defects, Congenital | 4 | 2021 | 659 | 1.120 |
Why?
| Repetitive Sequences, Nucleic Acid | 11 | 2019 | 104 | 1.100 |
Why?
| Vitamin B 12 | 3 | 2017 | 115 | 1.090 |
Why?
| Host Cell Factor C1 | 3 | 2017 | 13 | 1.080 |
Why?
| Segmental Duplications, Genomic | 3 | 2023 | 7 | 1.080 |
Why?
| Chromosome Disorders | 3 | 2021 | 34 | 1.070 |
Why?
| Intellectual Disability | 5 | 2021 | 129 | 1.050 |
Why?
| Gene Dosage | 11 | 2011 | 129 | 1.000 |
Why?
| Gene Duplication | 6 | 2011 | 62 | 0.930 |
Why?
| Williams Syndrome | 2 | 2021 | 15 | 0.850 |
Why?
| Translocation, Genetic | 11 | 2011 | 93 | 0.790 |
Why?
| Chromosome Breakage | 10 | 2010 | 21 | 0.780 |
Why?
| Genomic Structural Variation | 1 | 2021 | 7 | 0.760 |
Why?
| Chromosome Mapping | 12 | 2023 | 489 | 0.750 |
Why?
| Polymorphism, Single Nucleotide | 18 | 2015 | 1918 | 0.740 |
Why?
| Zebrafish | 4 | 2020 | 412 | 0.730 |
Why?
| Developmental Disabilities | 7 | 2021 | 240 | 0.690 |
Why?
| In Situ Hybridization, Fluorescence | 21 | 2019 | 310 | 0.690 |
Why?
| Repressor Proteins | 3 | 2017 | 369 | 0.650 |
Why?
| Mutation | 12 | 2021 | 3364 | 0.640 |
Why?
| Gene Deletion | 5 | 2011 | 355 | 0.630 |
Why?
| Seizures | 1 | 2021 | 344 | 0.600 |
Why?
| Genetic Variation | 9 | 2016 | 878 | 0.600 |
Why?
| Vestibular Diseases | 2 | 2015 | 22 | 0.590 |
Why?
| Genetic Diseases, X-Linked | 2 | 2017 | 22 | 0.590 |
Why?
| Chromosome Aberrations | 6 | 2018 | 134 | 0.580 |
Why?
| Hematologic Diseases | 2 | 2015 | 57 | 0.580 |
Why?
| Chromosomes, Human, Pair 16 | 5 | 2021 | 30 | 0.520 |
Why?
| Chromosomes, Human, Pair 1 | 4 | 2010 | 68 | 0.520 |
Why?
| Genome, Human | 6 | 2021 | 352 | 0.510 |
Why?
| Histone Demethylases | 1 | 2015 | 28 | 0.500 |
Why?
| Amino Acyl-tRNA Synthetases | 1 | 2015 | 28 | 0.490 |
Why?
| Chromosomes, Human, Pair 11 | 6 | 2003 | 58 | 0.480 |
Why?
| Neoplasm Proteins | 2 | 2015 | 385 | 0.480 |
Why?
| DNA-Binding Proteins | 5 | 2015 | 1316 | 0.480 |
Why?
| Face | 2 | 2015 | 167 | 0.470 |
Why?
| Blepharophimosis | 1 | 2014 | 3 | 0.470 |
Why?
| Skin Abnormalities | 1 | 2014 | 10 | 0.460 |
Why?
| Molecular Sequence Data | 22 | 2015 | 2790 | 0.460 |
Why?
| Frameshift Mutation | 1 | 2014 | 27 | 0.460 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2013 | 44 | 0.460 |
Why?
| Codon, Nonsense | 1 | 2014 | 38 | 0.450 |
Why?
| Brain Diseases | 1 | 2015 | 127 | 0.450 |
Why?
| Genes, X-Linked | 1 | 2013 | 17 | 0.450 |
Why?
| Hyperhomocysteinemia | 1 | 2013 | 24 | 0.450 |
Why?
| Amino Acid Metabolism, Inborn Errors | 1 | 2013 | 19 | 0.450 |
Why?
| Histone Acetyltransferases | 1 | 2014 | 50 | 0.440 |
Why?
| Syndrome | 10 | 2023 | 339 | 0.440 |
Why?
| Base Sequence | 19 | 2017 | 2114 | 0.430 |
Why?
| Autism Spectrum Disorder | 1 | 2016 | 322 | 0.400 |
Why?
| Zebrafish Proteins | 1 | 2014 | 246 | 0.400 |
Why?
| Down Syndrome | 1 | 2016 | 336 | 0.390 |
Why?
| Chromosomes, Human, Pair 13 | 2 | 2009 | 16 | 0.380 |
Why?
| Sequence Deletion | 5 | 2011 | 167 | 0.380 |
Why?
| Chromosomes, Human, Pair 10 | 2 | 2011 | 18 | 0.370 |
Why?
| Epilepsy | 1 | 2015 | 290 | 0.370 |
Why?
| Chromosomes, Human, Pair 21 | 2 | 2011 | 31 | 0.370 |
Why?
| Humans | 73 | 2023 | 115589 | 0.370 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2014 | 794 | 0.370 |
Why?
| Genomics | 2 | 2023 | 646 | 0.370 |
Why?
| Nuclear Proteins | 1 | 2015 | 594 | 0.370 |
Why?
| Phenotype | 14 | 2021 | 2829 | 0.360 |
Why?
| Carrier Proteins | 1 | 2014 | 701 | 0.360 |
Why?
| Infant | 19 | 2018 | 7979 | 0.350 |
Why?
| Databases, Genetic | 2 | 2010 | 208 | 0.330 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2008 | 49 | 0.320 |
Why?
| DNA Mutational Analysis | 7 | 2015 | 372 | 0.320 |
Why?
| Child | 21 | 2021 | 18489 | 0.320 |
Why?
| Congenital Abnormalities | 1 | 2008 | 74 | 0.310 |
Why?
| Autistic Disorder | 1 | 2010 | 163 | 0.300 |
Why?
| Genome-Wide Association Study | 7 | 2021 | 1217 | 0.290 |
Why?
| Child, Preschool | 18 | 2021 | 9133 | 0.290 |
Why?
| Genetic Predisposition to Disease | 7 | 2013 | 2125 | 0.280 |
Why?
| Nondisjunction, Genetic | 2 | 2010 | 3 | 0.270 |
Why?
| Branchial Region | 2 | 2017 | 33 | 0.270 |
Why?
| Meiosis | 2 | 2010 | 59 | 0.260 |
Why?
| Gene Knockdown Techniques | 3 | 2020 | 302 | 0.260 |
Why?
| Hyperglycinemia, Nonketotic | 2 | 2017 | 42 | 0.250 |
Why?
| DiGeorge Syndrome | 4 | 2015 | 19 | 0.250 |
Why?
| Amino Acid Sequence | 4 | 2020 | 2000 | 0.240 |
Why?
| Primates | 5 | 2019 | 111 | 0.240 |
Why?
| Rhabdoid Tumor | 4 | 2009 | 79 | 0.230 |
Why?
| Polymerase Chain Reaction | 8 | 2011 | 1000 | 0.220 |
Why?
| Gene Amplification | 4 | 2001 | 96 | 0.220 |
Why?
| Sequence Alignment | 6 | 2015 | 327 | 0.210 |
Why?
| Models, Genetic | 5 | 2011 | 570 | 0.200 |
Why?
| Male | 25 | 2021 | 55949 | 0.200 |
Why?
| Genetic Association Studies | 3 | 2020 | 343 | 0.200 |
Why?
| Transcription, Genetic | 2 | 2017 | 1310 | 0.190 |
Why?
| Tanzania | 1 | 2021 | 44 | 0.190 |
Why?
| Chromosome Breakpoints | 1 | 2021 | 6 | 0.190 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2021 | 53 | 0.190 |
Why?
| Forkhead Transcription Factors | 2 | 2014 | 171 | 0.180 |
Why?
| Animals | 16 | 2020 | 32102 | 0.180 |
Why?
| DNA, Complementary | 2 | 1999 | 258 | 0.180 |
Why?
| Spasms, Infantile | 1 | 2021 | 105 | 0.170 |
Why?
| 22q11 Deletion Syndrome | 1 | 2019 | 2 | 0.170 |
Why?
| Genotype | 8 | 2015 | 1787 | 0.170 |
Why?
| Receptors, GABA-A | 1 | 2020 | 88 | 0.170 |
Why?
| Karyotyping | 5 | 2018 | 102 | 0.170 |
Why?
| Protein Subunits | 1 | 2020 | 204 | 0.160 |
Why?
| Cell Differentiation | 2 | 2017 | 1700 | 0.160 |
Why?
| Nucleic Acid Hybridization | 3 | 2007 | 189 | 0.160 |
Why?
| Holoprosencephaly | 1 | 2018 | 8 | 0.160 |
Why?
| Cell Cycle Proteins | 2 | 1999 | 553 | 0.160 |
Why?
| Sequence Homology, Nucleic Acid | 6 | 2008 | 150 | 0.150 |
Why?
| Chromosomal Proteins, Non-Histone | 2 | 2009 | 99 | 0.150 |
Why?
| RNA Polymerase III | 1 | 1997 | 25 | 0.150 |
Why?
| AT Rich Sequence | 3 | 2010 | 4 | 0.150 |
Why?
| Cohort Studies | 2 | 2021 | 4944 | 0.140 |
Why?
| Gene Expression Regulation | 3 | 2017 | 2353 | 0.140 |
Why?
| Methylmalonic Acid | 1 | 2017 | 58 | 0.140 |
Why?
| Primary Cell Culture | 1 | 2017 | 149 | 0.140 |
Why?
| Sequence Analysis, DNA | 5 | 2011 | 732 | 0.140 |
Why?
| Vitamin B 12 Deficiency | 1 | 2017 | 74 | 0.140 |
Why?
| Polymorphism, Genetic | 4 | 2005 | 621 | 0.130 |
Why?
| Female | 21 | 2021 | 59913 | 0.130 |
Why?
| Glycine | 1 | 2017 | 156 | 0.130 |
Why?
| Glucose Transporter Type 3 | 1 | 2015 | 11 | 0.130 |
Why?
| Aminoacylation | 1 | 2015 | 12 | 0.130 |
Why?
| Motor Activity | 1 | 2020 | 633 | 0.130 |
Why?
| DNA Probes | 2 | 2008 | 59 | 0.120 |
Why?
| Heterozygote | 5 | 2020 | 252 | 0.120 |
Why?
| Chromosomal Instability | 2 | 2019 | 19 | 0.120 |
Why?
| Gene Expression | 1 | 2020 | 1436 | 0.120 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 225 | 0.120 |
Why?
| Forkhead Box Protein L2 | 1 | 2014 | 2 | 0.120 |
Why?
| RNA, Transfer | 1 | 2015 | 119 | 0.120 |
Why?
| Oxidoreductases | 1 | 2014 | 92 | 0.120 |
Why?
| Sulfurtransferases | 1 | 2013 | 9 | 0.120 |
Why?
| Glutaredoxins | 1 | 2013 | 11 | 0.110 |
Why?
| Exome | 1 | 2015 | 202 | 0.110 |
Why?
| Body Patterning | 1 | 2014 | 126 | 0.110 |
Why?
| Infant, Newborn | 4 | 2017 | 5077 | 0.110 |
Why?
| Inverted Repeat Sequences | 2 | 2010 | 13 | 0.110 |
Why?
| Neural Crest | 1 | 2014 | 117 | 0.110 |
Why?
| Prader-Willi Syndrome | 1 | 2013 | 25 | 0.110 |
Why?
| Urogenital Abnormalities | 1 | 2014 | 48 | 0.110 |
Why?
| Hypothyroidism | 1 | 2013 | 65 | 0.110 |
Why?
| Mental Disorders | 1 | 2021 | 902 | 0.110 |
Why?
| Comparative Genomic Hybridization | 4 | 2018 | 28 | 0.110 |
Why?
| Green Fluorescent Proteins | 1 | 2014 | 377 | 0.110 |
Why?
| Elastin | 1 | 2013 | 78 | 0.110 |
Why?
| Mosaicism | 2 | 2010 | 60 | 0.110 |
Why?
| Fibroblasts | 1 | 2017 | 839 | 0.110 |
Why?
| Microarray Analysis | 2 | 2010 | 119 | 0.100 |
Why?
| Chondrocytes | 1 | 2014 | 199 | 0.100 |
Why?
| Proteins | 2 | 2013 | 920 | 0.100 |
Why?
| Nucleic Acid Amplification Techniques | 2 | 2009 | 34 | 0.100 |
Why?
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 3 | 0.100 |
Why?
| Age of Onset | 1 | 2013 | 450 | 0.100 |
Why?
| Philadelphia | 1 | 2011 | 46 | 0.100 |
Why?
| Alleles | 4 | 2020 | 794 | 0.100 |
Why?
| Nerve Growth Factors | 1 | 2011 | 73 | 0.100 |
Why?
| RNA, Small Interfering | 1 | 2013 | 544 | 0.100 |
Why?
| HEK293 Cells | 1 | 2013 | 602 | 0.090 |
Why?
| Alu Elements | 2 | 2000 | 26 | 0.090 |
Why?
| Child Development Disorders, Pervasive | 1 | 2011 | 57 | 0.090 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2010 | 33 | 0.090 |
Why?
| Cell Movement | 1 | 2014 | 867 | 0.090 |
Why?
| Transcription Factors | 2 | 2009 | 1528 | 0.090 |
Why?
| Binding Sites | 1 | 2013 | 1177 | 0.090 |
Why?
| Stem Cells | 1 | 2014 | 546 | 0.090 |
Why?
| Cloning, Molecular | 3 | 2005 | 523 | 0.090 |
Why?
| Base Pairing | 1 | 2009 | 59 | 0.080 |
Why?
| Mice, Transgenic | 1 | 2014 | 1970 | 0.080 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2009 | 13 | 0.080 |
Why?
| Hematologic Neoplasms | 1 | 2011 | 136 | 0.080 |
Why?
| Blindness, Cortical | 1 | 2008 | 5 | 0.080 |
Why?
| Synaptic Transmission | 1 | 2011 | 232 | 0.080 |
Why?
| DNA, Circular | 1 | 2008 | 13 | 0.080 |
Why?
| Evolution, Molecular | 2 | 2019 | 440 | 0.080 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 2008 | 15 | 0.080 |
Why?
| Cleft Lip | 1 | 2008 | 31 | 0.080 |
Why?
| Brain | 3 | 2017 | 2373 | 0.080 |
Why?
| Gene Silencing | 1 | 2009 | 175 | 0.080 |
Why?
| RNA, Messenger | 2 | 2013 | 2574 | 0.080 |
Why?
| DNA Primers | 5 | 2003 | 514 | 0.080 |
Why?
| Neuroblastoma | 1 | 2009 | 130 | 0.080 |
Why?
| Haploinsufficiency | 3 | 2013 | 44 | 0.080 |
Why?
| Molecular Probe Techniques | 1 | 2008 | 9 | 0.080 |
Why?
| Young Adult | 3 | 2018 | 10470 | 0.080 |
Why?
| Protein Binding | 1 | 2013 | 1917 | 0.080 |
Why?
| Astrocytoma | 1 | 2008 | 109 | 0.070 |
Why?
| Synapses | 1 | 2011 | 336 | 0.070 |
Why?
| Beckwith-Wiedemann Syndrome | 1 | 2007 | 6 | 0.070 |
Why?
| Hernia, Diaphragmatic | 1 | 2007 | 66 | 0.070 |
Why?
| DNA | 4 | 2010 | 1356 | 0.070 |
Why?
| Central Nervous System | 1 | 2009 | 239 | 0.070 |
Why?
| Nerve Tissue Proteins | 1 | 2011 | 535 | 0.070 |
Why?
| Cleft Palate | 1 | 2007 | 45 | 0.070 |
Why?
| Learning | 1 | 2010 | 358 | 0.070 |
Why?
| Oncogene Proteins, Fusion | 1 | 2008 | 178 | 0.070 |
Why?
| Proto-Oncogene Proteins B-raf | 1 | 2008 | 192 | 0.070 |
Why?
| Gene Frequency | 4 | 2013 | 485 | 0.070 |
Why?
| Teratoma | 1 | 2007 | 92 | 0.070 |
Why?
| Adult | 8 | 2015 | 30719 | 0.070 |
Why?
| Research Design | 2 | 2009 | 946 | 0.070 |
Why?
| Pulmonary Alveoli | 1 | 2009 | 376 | 0.070 |
Why?
| Computational Biology | 1 | 2010 | 536 | 0.070 |
Why?
| Genes, Neurofibromatosis 1 | 1 | 2005 | 4 | 0.070 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2005 | 11 | 0.060 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 362 | 0.060 |
Why?
| Schizophrenia | 1 | 2009 | 418 | 0.060 |
Why?
| Nucleic Acid Conformation | 1 | 2008 | 672 | 0.060 |
Why?
| Gene Expression Profiling | 1 | 2011 | 1536 | 0.060 |
Why?
| Trisomy | 1 | 2005 | 68 | 0.060 |
Why?
| Conserved Sequence | 1 | 2005 | 219 | 0.060 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2009 | 330 | 0.060 |
Why?
| Mice, Knockout | 1 | 2010 | 2604 | 0.060 |
Why?
| Biological Evolution | 4 | 1996 | 417 | 0.060 |
Why?
| Chromosome Fragile Sites | 1 | 2003 | 1 | 0.060 |
Why?
| Chromosomes, Human, 21-22 and Y | 1 | 2003 | 4 | 0.060 |
Why?
| Genetic Testing | 2 | 2011 | 382 | 0.060 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2003 | 29 | 0.060 |
Why?
| Adolescent | 8 | 2018 | 17890 | 0.060 |
Why?
| Dinucleotide Repeats | 1 | 2003 | 4 | 0.050 |
Why?
| Mice | 4 | 2011 | 15052 | 0.050 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2003 | 57 | 0.050 |
Why?
| DNA Transposable Elements | 2 | 1995 | 100 | 0.050 |
Why?
| Cell Line | 4 | 2019 | 2651 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 930 | 0.050 |
Why?
| Consensus Sequence | 3 | 1997 | 70 | 0.050 |
Why?
| Genetic Markers | 2 | 1999 | 325 | 0.050 |
Why?
| Haplotypes | 1 | 2023 | 457 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2010 | 3580 | 0.050 |
Why?
| Adrenocorticotropic Hormone | 1 | 2021 | 148 | 0.050 |
Why?
| Brain Neoplasms | 1 | 2008 | 980 | 0.050 |
Why?
| Pan paniscus | 1 | 2000 | 5 | 0.040 |
Why?
| Contig Mapping | 1 | 2000 | 10 | 0.040 |
Why?
| Time Factors | 2 | 2008 | 6165 | 0.040 |
Why?
| Gorilla gorilla | 1 | 2000 | 19 | 0.040 |
Why?
| Physical Chromosome Mapping | 1 | 1999 | 16 | 0.040 |
Why?
| Artifacts | 1 | 2000 | 122 | 0.040 |
Why?
| Follow-Up Studies | 1 | 2008 | 4440 | 0.040 |
Why?
| HeLa Cells | 2 | 2000 | 567 | 0.040 |
Why?
| Enhancer Elements, Genetic | 1 | 2000 | 150 | 0.040 |
Why?
| Macaca mulatta | 1 | 2000 | 132 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2000 | 850 | 0.040 |
Why?
| Locomotion | 1 | 2020 | 81 | 0.040 |
Why?
| Phylogeny | 2 | 2001 | 805 | 0.040 |
Why?
| Larva | 1 | 2020 | 193 | 0.040 |
Why?
| Family Health | 1 | 1999 | 195 | 0.040 |
Why?
| Cytogenetics | 1 | 2018 | 11 | 0.040 |
Why?
| SMARCB1 Protein | 2 | 2009 | 16 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 1 | 1999 | 352 | 0.040 |
Why?
| Cosmids | 1 | 1997 | 6 | 0.040 |
Why?
| Chromosomes, Artificial, Bacterial | 2 | 2010 | 18 | 0.040 |
Why?
| Carcinoma, Embryonal | 1 | 1997 | 2 | 0.040 |
Why?
| DNA Replication | 1 | 1999 | 203 | 0.040 |
Why?
| Cardiovascular Diseases | 1 | 2008 | 1724 | 0.040 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1997 | 58 | 0.040 |
Why?
| Oligodeoxyribonucleotides | 1 | 1997 | 138 | 0.040 |
Why?
| Cytoplasm | 1 | 1997 | 255 | 0.030 |
Why?
| Random Allocation | 1 | 1997 | 337 | 0.030 |
Why?
| Recurrence | 2 | 2010 | 952 | 0.030 |
Why?
| Cells, Cultured | 3 | 2011 | 3914 | 0.030 |
Why?
| Pedigree | 2 | 2010 | 467 | 0.030 |
Why?
| RNA | 1 | 2000 | 819 | 0.030 |
Why?
| Cell Nucleus | 1 | 1997 | 553 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2013 | 2578 | 0.030 |
Why?
| Plasmids | 2 | 2008 | 345 | 0.030 |
Why?
| Hominidae | 1 | 1994 | 80 | 0.030 |
Why?
| Endocrine System | 1 | 2013 | 20 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 152 | 0.030 |
Why?
| Case-Control Studies | 2 | 2011 | 3022 | 0.030 |
Why?
| Prognosis | 2 | 2011 | 3339 | 0.030 |
Why?
| Aortic Stenosis, Supravalvular | 1 | 2013 | 6 | 0.030 |
Why?
| Chromosome Banding | 2 | 2005 | 21 | 0.030 |
Why?
| Fatal Outcome | 1 | 2013 | 286 | 0.030 |
Why?
| Aorta, Thoracic | 1 | 2015 | 246 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2017 | 1357 | 0.030 |
Why?
| Mitochondrial Proteins | 1 | 2013 | 219 | 0.020 |
Why?
| Penetrance | 1 | 2011 | 27 | 0.020 |
Why?
| Homologous Recombination | 1 | 2011 | 21 | 0.020 |
Why?
| Gene Order | 1 | 2011 | 24 | 0.020 |
Why?
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2011 | 1 | 0.020 |
Why?
| Sclerosis | 1 | 2011 | 11 | 0.020 |
Why?
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2011 | 6 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 14 | 0.020 |
Why?
| Collagen Type VI | 1 | 2011 | 5 | 0.020 |
Why?
| Monosomy | 1 | 2010 | 10 | 0.020 |
Why?
| Genotyping Techniques | 1 | 2011 | 70 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 58 | 0.020 |
Why?
| Muscular Dystrophies | 1 | 2011 | 36 | 0.020 |
Why?
| Spermatogenesis | 1 | 2010 | 52 | 0.020 |
Why?
| Health | 1 | 2010 | 74 | 0.020 |
Why?
| Gene Rearrangement | 1 | 2010 | 135 | 0.020 |
Why?
| Spermatozoa | 1 | 2010 | 84 | 0.020 |
Why?
| Receptor, Metabotropic Glutamate 5 | 1 | 2009 | 3 | 0.020 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2009 | 9 | 0.020 |
Why?
| Ultrasonography | 1 | 2013 | 641 | 0.020 |
Why?
| Jagged-1 Protein | 1 | 2009 | 22 | 0.020 |
Why?
| Serrate-Jagged Proteins | 1 | 2009 | 27 | 0.020 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2009 | 35 | 0.020 |
Why?
| Loss of Heterozygosity | 1 | 2009 | 41 | 0.020 |
Why?
| Capillaries | 1 | 2009 | 92 | 0.020 |
Why?
| Genes, Tumor Suppressor | 1 | 2009 | 78 | 0.020 |
Why?
| Alagille Syndrome | 1 | 2009 | 35 | 0.020 |
Why?
| Concept Formation | 1 | 2008 | 26 | 0.020 |
Why?
| Quality Control | 1 | 2008 | 147 | 0.020 |
Why?
| Population Groups | 1 | 2008 | 58 | 0.020 |
Why?
| Coloboma | 1 | 2008 | 4 | 0.020 |
Why?
| Pulmonary Veins | 1 | 2009 | 85 | 0.020 |
Why?
| Hybrid Cells | 2 | 2000 | 49 | 0.020 |
Why?
| Doxorubicin | 1 | 2009 | 290 | 0.020 |
Why?
| Models, Biological | 2 | 2008 | 1646 | 0.020 |
Why?
| Calcium-Binding Proteins | 1 | 2009 | 203 | 0.020 |
Why?
| Proto-Oncogene Proteins | 1 | 2011 | 609 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 350 | 0.020 |
Why?
| MAP Kinase Signaling System | 1 | 2008 | 275 | 0.020 |
Why?
| Biomarkers | 1 | 2017 | 3467 | 0.020 |
Why?
| Family | 1 | 2010 | 594 | 0.020 |
Why?
| DNA, Cruciform | 1 | 2005 | 4 | 0.020 |
Why?
| Blotting, Western | 1 | 2008 | 1153 | 0.020 |
Why?
| Genomic Instability | 1 | 2005 | 38 | 0.020 |
Why?
| COS Cells | 1 | 2005 | 175 | 0.020 |
Why?
| Fetus | 1 | 2009 | 702 | 0.020 |
Why?
| Primed In Situ Labeling | 1 | 2003 | 1 | 0.010 |
Why?
| Neurofibromin 1 | 1 | 2003 | 22 | 0.010 |
Why?
| Membrane Proteins | 1 | 2009 | 1024 | 0.010 |
Why?
| Centromere | 1 | 2003 | 42 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1490 | 0.010 |
Why?
| Introns | 1 | 2003 | 226 | 0.010 |
Why?
| Exons | 1 | 2003 | 300 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2009 | 2800 | 0.010 |
Why?
| Lymphocytes | 1 | 2003 | 344 | 0.010 |
Why?
| Obesity | 1 | 2013 | 2517 | 0.010 |
Why?
| DNA, Recombinant | 1 | 2000 | 42 | 0.010 |
Why?
| Telomere | 1 | 2003 | 204 | 0.010 |
Why?
| Blotting, Northern | 1 | 2000 | 194 | 0.010 |
Why?
| 3T3 Cells | 1 | 2000 | 137 | 0.010 |
Why?
| Chromosome Fragility | 1 | 2000 | 2 | 0.010 |
Why?
| Mutagenesis | 1 | 2000 | 170 | 0.010 |
Why?
| RNA Stability | 1 | 2000 | 93 | 0.010 |
Why?
| Prospective Studies | 1 | 2011 | 6264 | 0.010 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 1999 | 45 | 0.010 |
Why?
| Sequence Tagged Sites | 1 | 1997 | 4 | 0.010 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.010 |
Why?
| Chromosomes, Bacterial | 1 | 1997 | 7 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2007 | 2392 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 388 | 0.010 |
Why?
| Bacteriophages | 1 | 1997 | 76 | 0.010 |
Why?
| Risk Factors | 1 | 2009 | 8697 | 0.010 |
Why?
| Sequence Analysis | 1 | 1995 | 35 | 0.010 |
Why?
| Mutagenesis, Insertional | 1 | 1995 | 60 | 0.010 |
Why?
| Rodentia | 1 | 1995 | 44 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 65 | 0.010 |
Why?
| Africa | 1 | 1994 | 96 | 0.010 |
Why?
| Treatment Outcome | 1 | 2007 | 9159 | 0.010 |
Why?
| Middle Aged | 1 | 2013 | 26998 | 0.010 |
Why?
| Species Specificity | 1 | 1990 | 552 | 0.010 |
Why?
|
|
Shaikh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|